Zevenbergen Capital Investments’s NEVRO CORP. NVRO Stock Holding History

Zevenbergen Capital Investments’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-673,480	Closed	-$38.4M	–	85
2018 Q3	$38.4M	Buy	673,480 +5,750	+0.9%	+$359K	1.22%	33
2018 Q2	$53.3M	Buy	667,730 +54,430	+9%	+$4.52M	1.77%	20
2018 Q1	$53.2M	Sell	613,300 -22,030	-3%	-$1.78M	2.04%	21
2017 Q4	$43.9M	Buy	635,330 +16,595	+3%	+$1.33M	1.83%	24
2017 Q3	$56.2M	Sell	618,735 -24,340	-4%	-$2.08M	2.44%	15
2017 Q2	$47.9M	Buy	643,075 +194,695	+43%	+$15.6M	2.08%	20
2017 Q1	$42M	Buy	448,380 +133,955	+43%	+$12.1M	1.93%	21
2016 Q4	$22.8M	Buy	314,425 +188,725	+150%	+$16.2M	1.08%	33
2016 Q3	$13.1M	Buy	+125,700	New	+$11.4M	0.54%	38

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Zevenbergen Capital Investments's NVRO Position: Q4 2018 in Review

Zevenbergen Capital Investments sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 673,480 shares — an estimated $38.4M sold.

Zevenbergen Capital Investments first reported a position in NVRO in Q3 2016 and held it in 9 quarters. The position peaked at $56.2M in Q3 2017. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

Zevenbergen Capital Investments reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
Zevenbergen Capital Investments sold 673,480 NEVRO CORP. shares in Q4 2018, an estimated $38.4M.
Zevenbergen Capital Investments first reported a position in NEVRO CORP. in Q3 2016 and held it in 9 quarters.
Zevenbergen Capital Investments's NEVRO CORP. position peaked at $56.2M in Q3 2017.
157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2018, filed 14 Feb 2019.